| Q33950824 | A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients |
| Q73784859 | Association of cytomegalovirus interstitial pneumonitis with HLA-type following allogeneic bone marrow transplantation |
| Q44263247 | Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults |
| Q33969461 | Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients. |
| Q40870178 | Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation |
| Q40615300 | Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome |
| Q70940437 | Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation |
| Q34294838 | Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy |
| Q40424165 | Cytomegalovirus Infection in Marrow Transplantation |
| Q44603444 | Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation |
| Q74302230 | Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation |
| Q35922928 | Cytomegalovirus in hematopoietic stem cell transplant recipients |
| Q33660306 | Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: case report and review of the literature |
| Q43690751 | Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients |
| Q44603440 | Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis |
| Q40417896 | Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation |
| Q40395491 | Ganciclovir. An update of its therapeutic use in cytomegalovirus infection |
| Q44119543 | High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation |
| Q33966910 | Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients |
| Q34305094 | Infections following hematopoietic stem cell transplantation |
| Q33769714 | Infections in recipients of blood and marrow transplantation |
| Q54214517 | Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients. |
| Q33809769 | Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection |
| Q34294774 | Opportunistic infections after blood and marrow transplantation |
| Q37624896 | Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections |
| Q37488882 | Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir |
| Q35737132 | Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment |
| Q35583647 | Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients |
| Q39468915 | Quantitation of cytomegalovirus: methodologic aspects and clinical applications. |
| Q44245126 | Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation |
| Q35975542 | Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices |
| Q58657735 | Requirement for neutralizing antibodies to control bone marrow transplantation-associated persistent viral infection and to reduce immunopathology |
| Q33914361 | Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections |
| Q80525527 | Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients |
| Q88121050 | [Human cytomegalovirus pneumonia and intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a case report and literatures review] |
| Q70785376 | [Procedures of viral identification in respiratory infections] |
| Q52947953 | [Quantitative determination of CMV-DNA in saliva of patients with bone marrow and stem cell transplantation using TaqMan-PCR]. |